Contemporary use of arterial and venous conduits in coronary artery bypass grafting: anatomical, functional and clinical aspects

被引:0
作者
G. Cuminetti
S. Gelsomino
S. Curello
R. Lorusso
J. G. Maessen
J. C. A. Hoorntje
机构
[1] Maastricht University Medical Center,Department of Cardiology
[2] Maastricht University Medical Center,Department of Cardiac Surgery
[3] Spedali Civili and University of Brescia,undefined
来源
Netherlands Heart Journal | 2017年 / 25卷
关键词
Graft selection; Coronary artery bypass grafting; Myocardial revascularisation; Hybrid coronary artery revascularisation;
D O I
暂无
中图分类号
学科分类号
摘要
Although the benefits of using the left internal mammary artery to bypass the left anterior descending artery (LAD) have been extensively ascertained, freedom from major cardiovascular events and survival after coronary artery bypass grafting (CABG) also correlate with the completeness of revascularisation. Hence, careful selection of the second-best graft conduit is crucial for CABG success. The more widespread use of saphenous vein grafts contrasts with the well-known long-term efficacy of multiple arterial grafting, which struggles to emerge as the procedure of choice due to concerns over increased technical difficulties and higher risk of postoperative complications. Conduit choice is at the discretion of the operator instead of being discussed by the heart team, where cardiologists are not usually engaged in such decisions due to a hypothetical lack of technical knowledge. Furthermore, according to the ESC/EACTS guidelines, traditional CABG remains the gold standard for multi-vessel coronary artery disease with complex LAD stenosis, but hybrid procedures using percutaneous coronary intervention for non-LAD targets could combine the best of two worlds. With the aim of raising the cardiologist’s awareness of the surgical treatment options, we provide a comprehensive overview of the anatomical, functional and clinical aspects guiding the decision-making process in CABG strategy.
引用
收藏
页码:4 / 13
页数:9
相关论文
共 152 条
  • [1] Fanari Z(2015)Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials Cardiovasc Revasc Med 16 70-77
  • [2] Weiss SA(2003)A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes J Am Coll Cardiol 41 1293-1304
  • [3] Zhang W(2010)Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial Circulation 121 2645-2653
  • [4] Hoffman SN(2003)Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 1315-1323
  • [5] TenBrook JA(2007)Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy) Am J Cardiol 99 1044-1050
  • [6] Wolf MP(2016)A mixed treatment comparison for short- and long-term outcomes of bare-metal and drug-eluting coronary stents Int J Cardiol 202 448-462
  • [7] Morice MC(2000)Abciximab reduces mortality in diabetics following percutaneous coronary intervention J Am Coll Cardiol 35 922-928
  • [8] Serruys PW(2010)Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes Catheter Cardiovasc Interv 76 513-524
  • [9] Kappetein AP(2014)ESC/EACTS Guidelines on myocardial revascularisation: The Task Force on Myocardial Revascularisation of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 2014 2541-2619
  • [10] Moses JW(1986)Predictors of reoperation after myocardial revascularisation J Thorac Cardiovasc Surg 92 811-821